Atlas Trials

Stem Cell Transplantation To Treat High Risk Multiple Myeloma With Reduced Toxicity Myeloablative Conditioning Regimen

Clinical trial NCT00615589 · TERMINATED

Trial details

NCT number
NCT00615589
Sponsor
University of Michigan Rogel Cancer Center
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Multiple MyelomaPlasma Cell Leukemia
Start date
2008-02-01
Primary completion
2012-12-01
Enrollment
22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.